Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group (Q41743704)
scientific article published on April 1, 1998
Language:
(P31) (Q13442814)
(Q7318358)
(P304) 1358-1362
(P407) (Q1860)
(P433) 4
(P478) 16
(P577) Wednesday, April 1, 1998
Wednesday, April 1, 1998
(P921) (Q422232)
(Q238512)
(P953) http://intl.jco.org/cgi/content/abstract/16/4/1358
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.1998.16.4.1358
(P1433) (Q400292)
(P1476) "Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group" (language: en)
(P2093) A. Goldhirsch
A. S. Coates
M. Colleoni
M. Castiglione-Gertsch
R. D. Gelber
other details
description scientific article published on April 1, 1998

External Links